私かよく訪れている HC Support Network で、
HerpVワクチンを開発しているAgenusに対し、「Phase IIを早く開始して、FDA Fast Trackに申請するように」というメールを送ろう
という動きが出てきているようです!
これは、以前にこのブログでも紹介した「AIC316 AiCuris にEmail!」と同じような動きなのですが、開発元であるAgenusの反応が少し鈍そうな感じなので、「少しメールでプッシュしてみよう!」ということのようです。
メールアドレスとメール本文のサンプルを以下に載せておきますので、もしお時間があるようでしたら、出してみてはどうでしょうか?
【Email to Agenus】
To: jonae.barnes@agenusbio.com
Email: Agenus (HerpV) Action Needed
Herpes2 infects up to 20% of the US population over 18. Herpes2 infects up to 50% of the African American women. Herpes2 infects up to 75% of all unwed women over 45 years old. Herpes2 increases one's chances for acquiring AIDS.
This is not the domestic matter only in the US; uncountable number if people in the world are suffering from the disease and living with a huge worry for their future life.
The only medicinal treatment to both reduce outbreaks and viral shedding must be taken every day. It is also a costly proposition. There is no approved vaccine in the US and Japan which both reduces outbreaks and shedding.
We respectfully ask that Agenus design the Phase II testing such that upon successful completion the Company can immediately apply for Fast Track Status. This would be welcome news to MILLIONS and we will support your efforts in any way possible.
Thanks and please help us out. By helping the sufferers you will also help your shareholders!
0 件のコメント:
コメントを投稿